Spectra Plasmonics develops the Amplifi ID™ technology, a portable drug-checking system that provides rapid substance analysis and detailed breakdowns of sample components in under 10 minutes. This technology enables frontline organizations to detect trace amounts of dangerous substances, enhancing safety and informed decision-making in community drug strategies and harm reduction efforts.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for drug checking often lack portability and speed, hindering the ability of frontline organizations to rapidly analyze substances and identify potentially dangerous components in the field. This can lead to delayed responses and reduced effectiveness in harm reduction efforts and community drug strategies.
Solution
Spectra Plasmonics' Amplifi ID™ technology offers a portable drug-checking system that delivers rapid substance analysis, providing detailed breakdowns of sample components in under 10 minutes. The system enables frontline organizations to detect trace amounts of dangerous substances quickly and accurately, enhancing safety and informed decision-making. The Integrated Drug Landscape Dashboard enhances substance analysis with a suite of tools. This allows for more effective community drug strategies, harm reduction, and overdose prevention.
Target Audience
The primary users are organizations involved in community drug strategy, harm reduction, overdose prevention, public safety, and drug policy, including Syringe Service Programs, Community Health Groups, First Responder Groups, Public Safety Organizations, and State and Federal Health Authorities.
Features
- Portable system for on-site drug checking
- Provides results in under 10 minutes
- Detects trace amounts of dangerous substances
- Delivers a comprehensive breakdown of sample components
- Integrated Drug Landscape Dashboard for enhanced analysis
- Adaptable library that keeps device capabilities up to date with the changing drug supply